Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Developing Evidence to Decision Frameworks and an Interactive Evidence to Decision Tool for Making and Using Decisions and Recommendations in Health Care.

Rosenbaum SE, Moberg J, Glenton C, Schünemann HJ, Lewin S, Akl E, Mustafa RA, Morelli A, Vogel JP, Alonso-Coello P, Rada G, Vásquez J, Parmelli E, Gülmezoglu AM, Flottorp SA, Oxman AD.

Glob Chall. 2018 Jan 10;2(9):1700081. doi: 10.1002/gch2.201700081. eCollection 2018 Sep.

2.

Policymaker experiences with rapid response briefs to address health-system and technology questions in Uganda.

Mijumbi-Deve R, Rosenbaum SE, Oxman AD, Lavis JN, Sewankambo NK.

Health Res Policy Syst. 2017 May 3;15(1):37. doi: 10.1186/s12961-017-0200-1.

3.

Evidence summaries tailored to health policy-makers in low- and middle-income countries.

Rosenbaum SE, Glenton C, Wiysonge CS, Abalos E, Mignini L, Young T, Althabe F, Ciapponi A, Marti SG, Meng Q, Wang J, la Hoz Bradford AM, Kiwanuka SN, Rutebemberwa E, Pariyo GW, Flottorp S, Oxman AD.

Bull World Health Organ. 2011 Jan 1;89(1):54-61. doi: 10.2471/BLT.10.075481. Epub 2010 Nov 24.

4.

Development of a population pharmacokinetic model for atorvastatin acid and its lactone metabolite.

Narwal R, Akhlaghi F, Asberg A, Hermann M, Rosenbaum SE.

Clin Pharmacokinet. 2010 Oct;49(10):693-702. doi: 10.2165/11535980-000000000-00000.

PMID:
20818835
5.

Effects of epidermal growth factor receptor inhibitor-induced dermatologic toxicities on quality of life.

Joshi SS, Ortiz S, Witherspoon JN, Rademaker A, West DP, Anderson R, Rosenbaum SE, Lacouture ME.

Cancer. 2010 Aug 15;116(16):3916-23. doi: 10.1002/cncr.25090.

6.

Summary-of-findings tables in Cochrane reviews improved understanding and rapid retrieval of key information.

Rosenbaum SE, Glenton C, Oxman AD.

J Clin Epidemiol. 2010 Jun;63(6):620-6. doi: 10.1016/j.jclinepi.2009.12.014.

PMID:
20434024
7.

User testing and stakeholder feedback contributed to the development of understandable and useful Summary of Findings tables for Cochrane reviews.

Rosenbaum SE, Glenton C, Nylund HK, Oxman AD.

J Clin Epidemiol. 2010 Jun;63(6):607-19. doi: 10.1016/j.jclinepi.2009.12.013.

PMID:
20434023
8.

Population pharmacokinetics of mycophenolic acid and its 2 glucuronidated metabolites in kidney transplant recipients.

Sam WJ, Akhlaghi F, Rosenbaum SE.

J Clin Pharmacol. 2009 Feb;49(2):185-95. doi: 10.1177/0091270008329558.

PMID:
19179297
9.

User experiences of evidence-based online resources for health professionals: user testing of The Cochrane Library.

Rosenbaum SE, Glenton C, Cracknell J.

BMC Med Inform Decis Mak. 2008 Jul 28;8:34. doi: 10.1186/1472-6947-8-34.

10.

Dermatological reactions to the multitargeted tyrosine kinase inhibitor sunitinib.

Rosenbaum SE, Wu S, Newman MA, West DP, Kuzel T, Lacouture ME.

Support Care Cancer. 2008 Jun;16(6):557-66. doi: 10.1007/s00520-008-0409-1. Epub 2008 Feb 15. Review.

PMID:
18274784
11.

Population pharmacokinetics of cyclosporine in cardiopulmonary transplant recipients.

Rosenbaum SE, Baheti G, Trull AK, Akhlaghi F.

Ther Drug Monit. 2005 Apr;27(2):116-22.

PMID:
15795639
12.

A population pharmacokinetic analysis of nelfinavir mesylate in human immunodeficiency virus-infected patients enrolled in a phase III clinical trial.

Jackson KA, Rosenbaum SE, Kerr BM, Pithavala YK, Yuen G, Dudley MN.

Antimicrob Agents Chemother. 2000 Jul;44(7):1832-7.

13.

The application of population pharmacokinetics to the drug development process.

Jackson KA, Rosenbaum SE.

Drug Dev Ind Pharm. 1998 Dec;24(12):1155-62. Review.

PMID:
9876572
16.

Alternative medicines: pharmacologic and professional issues.

Glen VL, Campbell NA, Shimizu Y, Rosenbaum SE.

Med Health R I. 1998 Feb;81(2):43-7. No abstract available.

PMID:
9505064
17.

Knowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacists.

Generali JA, Danish MA, Rosenbaum SE.

Ann Pharmacother. 1995 Apr;29(4):365-9.

PMID:
7633012
19.

Regulation of protein kinase C gene expression by retinoic acid in B16 mouse melanoma cells.

Rosenbaum SE, Niles RM.

Arch Biochem Biophys. 1992 Apr;294(1):123-9.

PMID:
1550338
20.

Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project.

Scott HD, Thacher-Renshaw A, Rosenbaum SE, Waters WJ Jr, Green M, Andrews LG, Faich GA.

JAMA. 1990 Apr 4;263(13):1785-8.

PMID:
2313850
21.

Adverse drug reaction reporting systems: the United Kingdom and the United States.

Scott HD, Thacher A, Rosenbaum SE, Waters WJ Jr, Green M.

R I Med J. 1988 May;71(5):179-84. No abstract available.

PMID:
3387803
22.

Rhode Island physicians' recognition and reporting of adverse drug reactions.

Scott HD, Rosenbaum SE, Waters WJ, Colt AM, Andrews LG, Juergens JP, Faich GA.

R I Med J. 1987 Jul;70(7):311-6. No abstract available.

PMID:
3476980
23.

Practolol: aspects of its metabolism and ocular binding in the hamster.

Rosenbaum SE, Lindup WE, Orton TC.

Xenobiotica. 1986 Jun;16(6):567-73.

PMID:
3751112
24.

Practolol and its metabolites: tissue localization and retention in the hamster.

Rosenbaum SE, Lindup WE, Orton TC.

J Pharmacol Exp Ther. 1985 Aug;234(2):485-90.

PMID:
4020682
25.

Protective action of 2(3)-tert-butyl-4-hydroxyanisole (BHA) on acetaminophen-induced liver necrosis in male A/J mice.

Rosenbaum SE, Carlo JR, Boroujerdi M.

Res Commun Chem Pathol Pharmacol. 1984 Dec;46(3):425-35.

PMID:
6515131

Supplemental Content

Loading ...
Support Center